Sign in

CIK 0001347178

  • Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
030491827
Phone
+1 202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market sale Director sold 35,000 shares at $17.66 ($618,170)
  5. 4 Shares withheld for taxes SVP & Chief Medical Officer gave up 4,640 shares (to pay taxes)
  6. 4 Shares withheld for taxes SVP, CFO, Sec & Treasurer gave up 7,124 shares (to pay taxes)
  7. 4 Shares withheld for taxes President and CEO gave up 17,772 shares (to pay taxes)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market sale SVP & Chief Commercial Officer sold 107,500 shares at an average $12.03 ($1,293,277)
  12. 4 Open-market sale President and CEO sold 8,928 shares at $12.07 ($107,784)
  13. 4 Open-market sale SVP, CFO, Sec & Treasurer sold 3,348 shares at $12.07 ($40,421)
  14. 4 Exercise or conversion SVP & Chief Commercial Officer acquired 9,375 shares (option exercise)
  15. 4 Exercise or conversion President and CEO acquired 25,000 shares (option exercise)
  16. 4 Exercise or conversion SVP, CFO, Sec & Treasurer acquired 9,375 shares (option exercise)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 15 of 29 · 579 filings